Annual Book Value
$870.13 M
+$95.12 M+12.27%
December 31, 2023
Summary
- As of February 7, 2025, PCRX annual book value is $870.13 million, with the most recent change of +$95.12 million (+12.27%) on December 31, 2023.
- During the last 3 years, PCRX annual book value has risen by +$250.44 million (+40.41%).
- PCRX annual book value is now at all-time high.
Performance
PCRX Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Book Value
$749.58 M
-$129.69 M-14.75%
September 30, 2024
Summary
- As of February 7, 2025, PCRX quarterly book value is $749.58 million, with the most recent change of -$129.69 million (-14.75%) on September 30, 2024.
- Over the past year, PCRX quarterly book value has dropped by -$81.97 million (-9.86%).
- PCRX quarterly book value is now -15.98% below its all-time high of $892.16 million, reached on March 31, 2024.
Performance
PCRX Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Book Value Formula
Book Value = Total Assets − Total Liabilities
PCRX Book Value Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.3% | -9.9% |
| 3 y3 years | +40.4% | +5.6% |
| 5 y5 years | +170.9% | +5.6% |
PCRX Book Value Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +19.1% | -16.0% | +5.6% |
| 5 y | 5-year | at high | +145.2% | -16.0% | +111.2% |
| alltime | all time | at high | +1898.2% | -16.0% | +1649.1% |
Pacira BioSciences Book Value History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $749.58 M(-14.8%) |
| Jun 2024 | - | $879.28 M(-1.4%) |
| Mar 2024 | - | $892.16 M(+2.5%) |
| Dec 2023 | $870.13 M(+12.3%) | $870.13 M(+4.6%) |
| Sep 2023 | - | $831.55 M(+2.9%) |
| Jun 2023 | - | $807.98 M(+5.2%) |
| Mar 2023 | - | $768.04 M(-0.9%) |
| Dec 2022 | $775.01 M(+6.1%) | $775.01 M(+0.6%) |
| Sep 2022 | - | $770.12 M(+1.8%) |
| Jun 2022 | - | $756.64 M(+6.6%) |
| Mar 2022 | - | $709.58 M(-2.9%) |
| Dec 2021 | $730.41 M(+17.9%) | $730.41 M(+1.6%) |
| Sep 2021 | - | $718.60 M(+4.6%) |
| Jun 2021 | - | $687.17 M(+5.6%) |
| Mar 2021 | - | $650.82 M(+5.0%) |
| Dec 2020 | $619.69 M(+74.6%) | $619.69 M(+6.0%) |
| Sep 2020 | - | $584.69 M(+50.6%) |
| Jun 2020 | - | $388.15 M(+3.8%) |
| Mar 2020 | - | $374.04 M(+5.4%) |
| Dec 2019 | $354.94 M(+10.5%) | $354.94 M(+2.5%) |
| Sep 2019 | - | $346.16 M(+1.3%) |
| Jun 2019 | - | $341.65 M(+4.3%) |
| Mar 2019 | - | $327.52 M(+2.0%) |
| Dec 2018 | $321.23 M(+14.9%) | $321.23 M(+6.6%) |
| Sep 2018 | - | $301.27 M(+3.7%) |
| Jun 2018 | - | $290.51 M(+4.3%) |
| Mar 2018 | - | $278.52 M(-0.3%) |
| Dec 2017 | $279.48 M | $279.48 M(+5.5%) |
| Sep 2017 | - | $264.80 M(+1.4%) |
| Jun 2017 | - | $261.05 M(-3.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $270.63 M(+23.6%) |
| Dec 2016 | $218.98 M(+0.3%) | $218.98 M(+2.3%) |
| Sep 2016 | - | $214.15 M(-6.2%) |
| Jun 2016 | - | $228.35 M(+1.0%) |
| Mar 2016 | - | $226.17 M(+3.6%) |
| Dec 2015 | $218.39 M(+27.6%) | $218.39 M(+4.5%) |
| Sep 2015 | - | $209.01 M(+7.0%) |
| Jun 2015 | - | $195.28 M(+6.1%) |
| Mar 2015 | - | $184.02 M(+7.5%) |
| Dec 2014 | $171.15 M(+314.9%) | $171.15 M(+10.4%) |
| Sep 2014 | - | $155.07 M(+4.8%) |
| Jun 2014 | - | $147.97 M(+314.4%) |
| Mar 2014 | - | $35.71 M(-13.4%) |
| Dec 2013 | $41.25 M(-37.4%) | $41.25 M(-16.0%) |
| Sep 2013 | - | $49.12 M(-16.9%) |
| Jun 2013 | - | $59.14 M(-15.3%) |
| Mar 2013 | - | $69.79 M(+6.0%) |
| Dec 2012 | $65.86 M(+36.4%) | $65.86 M(-18.1%) |
| Sep 2012 | - | $80.44 M(-14.9%) |
| Jun 2012 | - | $94.50 M(+153.8%) |
| Mar 2012 | - | $37.24 M(-22.8%) |
| Dec 2011 | $48.27 M(-199.8%) | $48.27 M(+247.9%) |
| Sep 2011 | - | $13.88 M(-39.5%) |
| Jun 2011 | - | $22.93 M(-26.4%) |
| Mar 2011 | - | $31.15 M(-164.4%) |
| Dec 2010 | -$48.39 M(+110.8%) | -$48.39 M(+12.4%) |
| Sep 2010 | - | -$43.04 M(+25.5%) |
| Jun 2010 | - | -$34.30 M(+49.4%) |
| Dec 2009 | -$22.95 M(-406.7%) | -$22.95 M |
| Dec 2008 | $7.48 M | - |
FAQ
- What is Pacira BioSciences annual book value?
- What is the all time high annual book value for Pacira BioSciences?
- What is Pacira BioSciences annual book value year-on-year change?
- What is Pacira BioSciences quarterly book value?
- What is the all time high quarterly book value for Pacira BioSciences?
- What is Pacira BioSciences quarterly book value year-on-year change?
What is Pacira BioSciences annual book value?
The current annual book value of PCRX is $870.13 M
What is the all time high annual book value for Pacira BioSciences?
Pacira BioSciences all-time high annual book value is $870.13 M
What is Pacira BioSciences annual book value year-on-year change?
Over the past year, PCRX annual book value has changed by +$95.12 M (+12.27%)
What is Pacira BioSciences quarterly book value?
The current quarterly book value of PCRX is $749.58 M
What is the all time high quarterly book value for Pacira BioSciences?
Pacira BioSciences all-time high quarterly book value is $892.16 M
What is Pacira BioSciences quarterly book value year-on-year change?
Over the past year, PCRX quarterly book value has changed by -$81.97 M (-9.86%)